Gender differences in drug responses - PubMed (original) (raw)
Review
Gender differences in drug responses
Flavia Franconi et al. Pharmacol Res. 2007 Feb.
Abstract
This review summarizes gender differences (GDs) in drug response. Although GDs have been described both in pharmacodynamics and pharmacokinetics, their role in clinical practice is not yet completely elucidated. The evidence that women have been less enrolled in clinical trials and that a gender-specific analysis usually is not included in the evaluation of results, contributes largely to this uncertainty. Consequently, adverse drug reactions (ADRs) are still higher in females than in males. Since sex is a fundamental biological variable that cannot be discounted, GDs in pharmacology have to be considered in order to improve drug safety efficacy and to optimize medical therapy both in men and women.
Similar articles
- Gender-related considerations in clinical pharmacology and drug therapeutics.
Xie CX, Piecoro LT, Wermeling DP. Xie CX, et al. Crit Care Nurs Clin North Am. 1997 Dec;9(4):459-68. Crit Care Nurs Clin North Am. 1997. PMID: 9444169 Review. - Sex differences in drug effects: interaction with sex hormones in adult life.
Spoletini I, Vitale C, Malorni W, Rosano GM. Spoletini I, et al. Handb Exp Pharmacol. 2012;(214):91-105. doi: 10.1007/978-3-642-30726-3_5. Handb Exp Pharmacol. 2012. PMID: 23027447 Review. - [Gender-related differences in pharmacokinetics and pharmacodynamics].
Thürmann PA. Thürmann PA. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 May;48(5):536-40. doi: 10.1007/s00103-005-1039-0. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005. PMID: 15887063 German. - Sex and gender influences on pharmacological response: an overview.
Franconi F, Campesi I. Franconi F, et al. Expert Rev Clin Pharmacol. 2014 Jul;7(4):469-85. doi: 10.1586/17512433.2014.922866. Epub 2014 May 24. Expert Rev Clin Pharmacol. 2014. PMID: 24857340 Review. - [GENDER AND SEX ASPECTS IN PHARMACOLOGY].
Glezerman M. Glezerman M. Harefuah. 2024 Jul;163(7):457-461. Harefuah. 2024. PMID: 39569956 Review. Hebrew.
Cited by
- The "his and hers" of the renin-angiotensin system.
Hilliard LM, Sampson AK, Brown RD, Denton KM. Hilliard LM, et al. Curr Hypertens Rep. 2013 Feb;15(1):71-9. doi: 10.1007/s11906-012-0319-y. Curr Hypertens Rep. 2013. PMID: 23180053 Review. - Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures.
Vazquez B, Yang H, Williams B, Zhou S, Laurenza A. Vazquez B, et al. Epilepsia. 2015 Jul;56(7):e90-4. doi: 10.1111/epi.13019. Epub 2015 Jun 11. Epilepsia. 2015. PMID: 26096637 Free PMC article. Clinical Trial. - Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats.
Ma YR, Qin HY, Jin YW, Huang J, Han M, Wang XD, Zhang GQ, Zhou Y, Rao Z, Wu XA. Ma YR, et al. Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):559-65. doi: 10.1007/s13318-015-0278-1. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25876759 - Gender differences in kidney function.
Sabolić I, Asif AR, Budach WE, Wanke C, Bahn A, Burckhardt G. Sabolić I, et al. Pflugers Arch. 2007 Dec;455(3):397-429. doi: 10.1007/s00424-007-0308-1. Epub 2007 Jul 19. Pflugers Arch. 2007. PMID: 17638010 Review. - Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?
De Francia S, Berchialla P, Armando T, Storto S, Allegra S, Sciannameo V, Soave G, Sprio AE, Racca S, Caiaffa MR, Ciuffreda L, Mussa MV. De Francia S, et al. Eur J Clin Pharmacol. 2022 Jun;78(6):1029-1038. doi: 10.1007/s00228-022-03298-y. Epub 2022 Feb 22. Eur J Clin Pharmacol. 2022. PMID: 35192004 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical